McCulloch Kevin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$109,475.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of McCulloch Kevin

According to the SEC Form 4 filings, McCulloch Kevin, being in a position of

  1. See Remarks at Xeris Biopharma Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 175000 shares for $1.48M,
    over all time since 2025-06-13, has bought 25000 shares for $109,475, and sold 175000 shares for $1.48M.

Biography of McCulloch Kevin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,481,1796100

Comparison of Insiders on Amount of Buys and Sells

2026-10-01SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
15,000
0.0088%
$9.41$141,120+11.46%
2026-09-28SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
25,000
0.0147%
$10.00$250,000+3.81%
2026-09-01SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
15,000
0.0087%
$8.49$127,308+17.5%
2026-08-03SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
15,000
0.0087%
$8.02$120,240+7.5%
2026-07-01SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
90,000
0.0523%
$8.03$722,511+8.25%
2026-01-08SaleXeris Biopharma Holdings, Inc.
XERS
See Remarks
15,000
0.0089%
$8.00$120,000-8.98%
2025-06-13PurchaseXeris Biopharma Holdings, Inc.
XERS
See Remarks
25,000
0.0157%
$4.38$109,475+58.85%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.